Antioxidant 1035 | CAS:41484-35-9

We serve Antioxidant 1035 CAS:41484-35-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Antioxidant 1035

Synonyms：
diylester
fenozan30
MFCD00059346
EINECS 255-392-8
ANTIOXIDANT 1035
Thiodiethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate)
IRGANOX 1035
Thanox1035
4-hydroxy-3,5-di-tert-butylphenylpropionicacidthioglycolate
2,2'-Thiodiethylene Bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]
 
Molecular Formula: C38H58O6S
Molecular Weight:  642.92900

TEST UNIT SPECIFICATION
APPEARANCE   WHITE POWDER
VOLATILES % 0.50MAX
SOLUBILITY   CLEAR
TRANSMITTANCE    
425nm % 95.00MIN
500nm % 97.00MIN
MELTING POINT ℃ 65.00MIN
ASH % 0.10MAX
ASSAY % 98.00MIN
 
Our company is a professional supplier of functional material additives. Our products include antioxidants, ultraviolet absorbers, light stabilizers, photoinitiators, heat stabilizers, nucleating agents, flame retardants, polyurethane chain extenders, nano light absorbing materials, antibacterial materials, functional masterbatches, colorants etc. After years of steadfast industry accumulation and technological innovation, a relatively complete additive industry chain has been formed in the rubber and plastic industry, ink industry, coating industry, textile printing and dyeing industry, functional resin and other industries. Significant achievements have been made in the field of additives.
 
 
 



Contact us for information like Antioxidant 1035 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2′-Thiodiethylene Bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-hydroxy-3,5-di-tert-butylphenylpropionicacidthioglycolate Use and application,MFCD00059346 technical grade,usp/ep/jp grade.


Related News: Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production.Cyclohexene, 1-methoxy- manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).1,4,7,10-tetraazacyclododecane supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).4(1H)-Pyridinone, 3-[(4-methoxyphenyl)methoxy]-2-methyl- vendor Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.